Moderna
Moderna to build UK centre for mRNA vaccines
The company and the health ministry said in a joint statement that work could start on the manufacturing and research and development centre as early as this...
-
Youngest age group approved for Pfizer and Moderna vaccines in US
The agency authorized Moderna's two-dose vaccine for children aged six months to five years, and three doses of Pfizer's shots for those between six months and four years old.
-
Moderna announces positive results for Omicron vaccine
This so-called "bivalent" vaccine was tested in a trial of more 850 adults, who had all received their first three doses of Moderna's original Spikevax vaccine.
-
SA medical scientists to evaluate efficacy of Moderna COVID jab as booster shot
The Sisonke study team is launching the Sherpa Study that will assess the Moderna booster in protecting against COVID-19 infections and severe COVID-19 disease among healthcare workers.
-
How drug companies are sidestepping the WHO’s technology transfer hub in Africa
The decisions by BioNTech and Moderna to invest in other vaccine sites in African and not assist the mRNA Technology Transfer Hub in South Africa will prolong the social and economic costs of the pandemic, says David Richard Walwyn.
-
Moderna boss says vaccines likely no match for Omicron: FT
Stephane Bancel's warning came as G7 health ministers held emergency talks on the new variant, which is spreading around the world and prompting nations to close their borders once again or impose fresh travel restrictions.
-
Pfizer, BioNTech, Moderna making more than R15,000 profit every second: analysis
The Alliance estimates that the trio will make pre-tax profits of $34 billion this year between them, which works out to over $1,000 a second, $65,000 a minute or $93.5 million a day.
-
Cyprus to vaccinate minors aged 16 and 17
Cyprus has seen a new surge in cases, with Saturday's 226 infections hitting a six-week high. The sharp rise is blamed on the more potent Delta variant spreading in the community and the low vaccination rate among the under 30s.
-
Moderna seeks approval of COVID-19 vaccine for teens in Europe, Canada
The firm said it also plans to file for emergency approval with the Food and Drug Administration in the United States, where the Pfizer/BioNTech jab is already being administered to adolescents age 12 and up.
-
Covax signs deal for 500m Moderna COVID-19 vaccine doses
The doses, to come on stream from October at the earliest, will broaden out the portfolio of vaccines in the Covax scheme, which has so far been heavily reliant on the AstraZeneca vaccine and hit by delays.
-
Stanford scientists post mRNA sequence for Moderna vaccine on Github - reports
Scientists Massa Shoura and Andrew Fire have posted the full sequence of the vaccine on GitHub for all to see, according to Motherboard.
-
Moderna: Vaccine aimed at variant first identified in SA is ready for testing
The variant is considered among the more dangerous of current mutations because it evades some of the blocking action of antibodies that target the older coronavirus strain.
-
More than 100 million vaccinated across the globe
None of the world's 29 poorest countries has formally started mass vaccination drives, while the richest nations have given more than two-thirds of jabs administered.
-
Moderna says COVID vaccine effective against variants identified in SA, UK
The company has also begun preclinical studies on a booster specifically for the variant initially identified by South African scientists.
-
Moderna COVID-19 vaccine confers at least 3 months immunity - study
The vaccine, called mRNA-1273, is administered in two injections given 28 days apart.
-
Trump virus advisor quits as vaccine hopes given new boost
Scott Atlas, a favoured coronavirus advisor of the US president, who tweeted in October "Masks work? NO," has submitted his resignation, effective as of December 1, Fox News reported.
-
Moderna says will request US, Europe vaccine authorisation Monday
If the US Food and Drug Administration agrees it is safe and effective, the first of the drug's two doses could be injected into the arms of millions of Americans by the middle of December.
-
The COVID-19 vaccine: 'SA is at the bottom of the queue'
The recent success of vaccine trials has provided some global hope of beating COVID-19. But when will South Africans be able to get their hands on it? We spoke to the country's top scientists to find.
-
ANALYSIS: Moderna follows Pfizer with good vaccine news – what does this mean?
Many more vaccine trial results are likely to follow in the coming months, so it’s necessary to dig deeper to find out exactly what any new results mean.
